1Claypool WD, Rogers RM, Matuschak GM. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis(phospholipidosis). Chest, 1984, 85(4): 8.
2Wang X, Liu F, Bewig B. Analysis of the GM-CSF and GMCSF/IL-3/IL-5 receptor common beta chain in a patient with pulmonary alveolar proteinosis. Chin Med J(Engl), 2002, 115(1):76.
3Seymour JF, Doyle IR, Nakata K, et al. Relationship of antiGM-CSF antibody concentration,surfactant proteinA and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis.Thorax, 2003,58(3):7.
4Ando J, Tamayose K, Sugimoto K, et al. Late appearance of t (1;19)(q11;q11) in myelodysplastic syndrome associated with dysplastic eosinophilia and pulmonary alveolar proteinosis. Cancer Genet Cytogenet, 2002,139(1):7.
5Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis:progress in the first 44 years. Am J Respir Crit Care Med,2002,166:215.
6Prakash UB, Barham SS, Carpenter HA, et al. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc, 1987, 62(6):499.
7Singh G, Katyal SL, Bedrossian CW, et al. Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it. Chest, 1983,83(1):6.
8Godwin JD, Muller NL, Takasugi JE, et al. Pulmonary alveolar proteinosis: CT findings. Radiology, 1988, 169(3): 13.
9Murayama S, Murakami J, Yabuuchi H, et al. "Crazy paving appearance" on high resolution CT in various diseases J.J Comput Assist Tomogr, 1999, 23:749.
10Arbiser ZK, Guidot DM, Pine JR, et al. Pulmonary alveolar proteinosis mimicking idiopathic pulmonaryfibrosis. Ann Diagn Pathol, 2003, 7(2): 6.
